← Research library

Effect of piracetam on recovery and rehabilitation after stroke: a double-blind, placebo-controlled study

Randomized study in people · 1994

What was studied
158 post-stroke rehabilitation patients; 137 assessed after treatment and 88 at 24 weeks
Main finding
A 12-week placebo comparison reported an aphasia signal but no demonstrated improvement in activities of daily living. Persistence at 24 weeks was unresolved.

Reported findings and study design

The 158-patient rehabilitation trial found a favorable aphasia analysis at 12 weeks (p=0.02), but no demonstrated daily-living benefit. Only 88 patients were available at 24 weeks, leaving persistence uncertain.

Population or model 158 post-stroke rehabilitation patients; 137 assessed after treatment and 88 at 24 weeks

Results · Primary indexed abstract checked
MeasureResultComparison, timing and statistics
Aachen Aphasia Test multivariate comparisonFavored piracetam at 12 weeksp=0.02
Activities of daily livingNo demonstrated treatment effect
Follow-up availability158 enrolled; 137 after treatment; 88 at week 24

Source for these results ↗ · Reviewed 2026-11-01

Study limitations and source details

Study limitations

  • Substantial loss to later follow-up limits interpretation.
  • Aphasia findings require confirmation and do not establish healthy-person cognitive enhancement.

Source details

Journal article

Europe PMC indexed abstract checked; complete trial methods not reviewed.

Abstract

Sources checked

Citation

Randomized trialEnglish abstract

Enderby P, Broeckx J, Hospers W, Schildermans F, Deberdt W. Effect of piracetam on recovery and rehabilitation after stroke: a double-blind, placebo-controlled study Clinical neuropharmacology

Study source ↗ · DOI 10.1097/00002826-199408000-00003 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards